Veracyte (VCYT) Income from Continuing Operations (2012 - 2026)

Veracyte has disclosed Income from Continuing Operations across 15 years of filings, most recently posting 28674000.0 for Q1 2026.

• Income from Continuing Operations for Q1 2026 came in at 28674000.0, up 306.9% year-over-year; the trailing twelve-month figure through Mar 2026 was 88009000.0 (up 166.3% YoY), and the FY2025 annual result was 66352000.0, up 174.89% from the prior year.
• Income from Continuing Operations came in at 28674000.0 for Q1 2026 at Veracyte, down from 41148000.0 in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of 41148000.0 in Q4 2025 to a low of 29572000.0 in Q3 2023.
• The 5-year median for Income from Continuing Operations is 1864000.0 (2024), against an average of 488235.29.
• Across the five-year window, Income from Continuing Operations sank 640.92% in 2023 and jumped 704.77% in 2025, its largest moves.
• Veracyte's Income from Continuing Operations stood at 3817000.0 in 2022, then tumbled by 640.92% to 28281000.0 in 2023, then soared by 118.08% to 5113000.0 in 2024, then surged by 704.77% to 41148000.0 in 2025, then sank by 30.31% to 28674000.0 in 2026.
• The last three Income from Continuing Operations figures came in at 28674000.0 (Q1 2026), 41148000.0 (Q4 2025), and 19137000.0 (Q3 2025), per Business Quant data.